Awards/COOPERATIVE AGREEMENT (B)

$57,141,857

Department of Health and Human Services·National Institutes of Health

biotechactiveONGOING · MOD OF 2007 CONTRACT

WORK BEGAN2007-01-15·LATEST ACTION2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI069412_075

Award description

HARVARD MEDICAL SCHOOL VACCINE CLINICAL TRIALS UNIT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds ongoing vaccine clinical trials and development research at Harvard Medical School.

Sub-sectors

vaccine-developmentclinical-trialsnih-research

Why this matters

Sustains critical U.S. vaccine development capacity and pandemic preparedness infrastructure.

Supply-chain signal

Upstream R&D funding that feeds vaccine manufacturing, distribution, and public health deployment.

U.S.–China competition angle

Reflects U.S. commitment to maintaining vaccine innovation and biotech leadership.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-08. Cost: $0.018899.

Period of performance

Start

2007-01-15

End

2027-11-30

Status

activein 505 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_UM1AI069412_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.